SCHULZE GAIL 4
4 · CERUS CORP · Filed Dec 15, 2020
Insider Transaction Report
Form 4
CERUS CORPCERS
SCHULZE GAIL
Director
Transactions
- Sale
Common Stock
2020-12-14$7.48/sh−15,000$112,128→ 47,393 total - Sale
Common Stock
2020-12-14$7.27/sh−47,393$344,689→ 0 total - Exercise/Conversion
Option (Right to Buy)
2020-12-14−15,000→ 0 totalExercise: $2.48Exp: 2021-01-02→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-12-14$2.48/sh+15,000$37,200→ 62,393 total
Footnotes (4)
- [F1]The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.28 to $7.595 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- [F2]The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.325 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- [F3]The option became exercisable in 12 equal monthly installments after the grant date.
- [F4]Not applicable.